Brugada syndrome history and symptoms

Jump to navigation Jump to search

Brugada syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Brugada syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Examples of Type I Brugada Syndrome

Chest X Ray

Echocardiography or Ultrasound

Electrophysiologic Studies

Genetic Testing

Treatment

Treatment

Drugs to Avoid

Drugs to Preferably Avoid

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Brugada syndrome history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Brugada syndrome history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Brugada syndrome history and symptoms

CDC on Brugada syndrome history and symptoms

Brugada syndrome history and symptoms in the news

Blogs on Brugada syndrome history and symptoms

Directions to Hospitals Treating Brugada syndrome

Risk calculators and risk factors for Brugada syndrome history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Patients with Brugada syndrome will sometimes have a family history of sudden cardiac death and a personal history of of arrhythmias. If patients are symptomatic they often have symptoms of syncope, seizures, agonal breathing, difficulty breathing, and patients may even present with sudden death. These symptoms most often come on either at rest or during sleep.

History

  • Brugada syndrome is diagnosed when a Type 1 ST-segment elevation is observed in more than one right precordial lead (V1-V3), in the presence or absence of sodium channel blocking agent, in conjunction with one or more of the following:
  1. Family history of sudden cardiac death (SCD) (<45 years old)
  2. Documented ventricular fibrillation (VF)
  3. Polymorphic ventricular tachycardia
  4. Coved-type ECG changes in family members
  5. Inducibility of ventricular tachycardia (VT) with programmed electrical stimulation (PES)
  • The diagnosis is also considered positive when a Type 2 (saddleback pattern) or Type 3 ST-segment elevation is observed in more than one right precordial lead under baseline conditions and can be converted to the diagnostic Type 1 pattern occurs upon exposure to a sodium channel blocker.

Symptoms

These complications typically occur when an affected person is resting or asleep:

References

Template:WH Template:WS CME Category::Cardiology